Bionano Genomics, Inc. logo

Bionano Genomics, Inc.

0001411690

Bionano develops and offers optical genome mapping (OGM) solutions. Their Stratys™ and Saphyr™ systems, along with VIA™ software, enable the discovery of structural variants in the genome. Bionano positions itself as an innovator in genomics, focusing on improving health through advanced technology.

87
Sehr Vertrauenswürdig
Vertrauensscore

Offizielles Register

Rechtlicher Name
Bionano Genomics, Inc.
Organisationsnummer
0001411690
Umsatzsteuer-ID
261756290
Unternehmensstatus
Active
Adresse
9540 TOWNE CENTRE DRIVE, SAN DIEGO, CA 92121
Branchencodes
3826: Laboratory Analytical Instruments

Zuletzt überprüft: 1/2/2026

KI-Qualitätsanalyse

Branche
Biotechnology
SSL/HTTPS
Sicher
Professionelle E-Mail
Ja
Kontakt E-Mail
support@bionano.com

Vertrauensscore-Details

Register verifiziert35/35
Qualitätsbewertung52/60
Nachrichtenstimmung0/5

Schnellzugriff

Zuletzt aktualisiert: 1/2/2026

🌟 Ähnliche vertrauenswürdige Unternehmen

Context Therapeutics Inc.

Context Therapeutics Inc. logo
86/100 · Sehr Vertrauenswürdig

Context Therapeutics is dedicated to advancing the treatment of solid tumors through the development of next-generation T cell engaging (TCE) bispecific antibody therapies. Their innovative pipeline features clinical-stage bispecific therapeutics designed to harness the immune system for targeted cancer eradication. The company focuses on innovative immunotherapeutic solutions, transforming cancer care and improving outcomes for patients.

2001 MARKET STREET, USA
Profil ansehen

AGENUS INC

AGENUS INC logo
86/100 · Sehr Vertrauenswürdig

Agenus is a biotechnology company focused on developing and commercializing immuno-oncology therapies. Their key products include botensilimab and balstilimab, which are in clinical trials for various cancers. The company is positioned as an innovator in the development of next-generation immunotherapies.

3 FORBES ROAD, USA
Profil ansehen

Evaxion A/S

Evaxion A/S logo
77/100 · Vertrauenswürdig

Evaxion utilizes its AI-Immunology™ platform to challenge and improve standardized treatments. In oncology, they create personalized therapies, tailoring treatment to the individual. For infectious diseases, they design next-generation vaccines to address unmet medical needs. Their AI platform accelerates vaccine target discovery, design, and development.

DR NEERGAARDS VEJ 5F, USA
Profil ansehen